Fennec Pharmaceuticals (FENC) Non-Current Assets (2019 - 2026)
Fennec Pharmaceuticals (FENC) recorded Non-Current Assets of $3.25 million in Q2 2026, down 20.3% from $4.08 million a year earlier.
Powered by 
Analysis
Fennec Pharmaceuticals (FENC) Non-Current Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Fennec Pharmaceuticals reported Non-Current Assets of $3.51 million, up 326.8% from FY2024.
- Annual Non-Current Assets has a four-year compound annual growth rate of 237.6% (FY2021 to FY2025).
- Across earlier years, Non-Current Assets came in at $822,000 in FY2024, $6,000 in FY2023 (-97.2%), $211,000 in FY2022 (+681.5%) and $27,000 in FY2021.
- Quarterly Non-Current Assets has ranged from $6,000 in Q4 2023 to $4.08 million in Q2 2025 over the past five years.
- On a year-over-year basis, Non-Current Assets rose in four of the last five quarters, with growth averaging 217.8%.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 833.0% in Q2 2024, against a decline of 97.2% in Q4 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Fennec Pharmaceuticals | 383.62 Mn | 264.93 Mn | 17.15 Mn | 3.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.25 Mn |
| Dec 31, 2025 | 3.51 Mn |
| Sep 30, 2025 | 3.20 Mn |
| Jun 30, 2025 | 4.08 Mn |
| Mar 31, 2025 | 3.43 Mn |
| Dec 31, 2024 | 822,000.00 |
| Sep 30, 2024 | 956,000.00 |
| Jun 30, 2024 | 989,000.00 |
| Mar 31, 2024 | 1.02 Mn |
| Dec 31, 2023 | 6,000.00 |
| Sep 30, 2023 | 82,000.00 |
| Jun 30, 2023 | 106,000.00 |
| Mar 31, 2023 | 159,000.00 |
| Dec 31, 2022 | 211,000.00 |
| Sep 30, 2022 | 264,000.00 |
| Jun 30, 2022 | 14,000.00 |
| Mar 31, 2022 | 21,000.00 |
| Dec 31, 2021 | 27,000.00 |
| Sep 30, 2021 | 35,000.00 |
| Jun 30, 2021 | 41,000.00 |
API Access
Fennec Pharmaceuticals Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=FENC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "FENC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=FENC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();